Remote diagnostic financing blowout: Capital Focus Mobile Medical New Blue Ocean
Uncomfortable, no need to go out, open a computer or mobile phone, and let doctors diagnose and treat through video. This new Internet-based inquiry mode is getting more and more into the lives of citizens, and aiming at mobile medical blue ocean, many hospitals and enterprises. Also speed up the layout of "Internet +". Recently, the Internet medical comprehensive enterprise Qi Lekang announced the completion of a new round of financing, this round of investment by Tianyi Investment Group (Zhongwei Fund), Sequoia Capital, Jingdong and other joint efforts. The various platforms and product forms in the mobile medical field are also blooming, and continue to gain favor from the capital market.
Remote diagnosis brings convenience to patients
In May last year, the pharmaceutical e-commerce company Seven Lekang and the Liwan District Central Hospital in Guangzhou jointly established the Qikang Qilekang Internet Hospital, which was officially launched into mobile medical care. At present, the diagnostic platform built by Qi Lekang has brought together more than 300,000 doctors in more than 300 cities in 34 provinces (cities, districts) and over 10 million patients. The daily consultation volume exceeds 100,000.
It is reported that after the completion of this financing, Qi Lekang will focus on the remote secondary diagnosis and treatment of chronic diseases in 2017, in addition to recruiting more doctors to station in the “Seven Le Kang doctor†platform, strengthen the “doctor partner†team, upgrade product technology and The function will also continue to help doctors to practice more than a new Internet hospital.
According to China Industrial Information Network, there are more than 260 million chronically diagnosed patients in China. According to industry insiders, a large number of patients with chronic diseases have brought a promising market space for remote diagnosis. After the first diagnosis is completed by offline patients, it is usually not necessary to run the hospital frequently. The follow-up is mainly treated with long-term medication, so the remote diagnosis platform can be used for the evaluation of the condition. Through the second diagnosis through the remote diagnosis platform, prescriptions can be issued and drugs can be purchased online, which greatly saves patients' medical time and transportation costs.
For the hospital, the cross-diagnosis through the remote diagnosis platform not only improves the efficiency of medical services, but also provides a platform for doctors to practice more.
Internet medical financing blowout
According to Zhiyan Consulting Group's “2016-2022 China Mobile Medical Industry Operation Situation and Development Prospect Analysis Reportâ€, the mobile medical market model is expected to reach 12.53 billion yuan by 2017. The huge market has attracted a lot of capital to enter the “Nuggetsâ€.
In addition to Qi Lekang, which has just completed financing, various platforms and product forms in the mobile medical field are also blooming, and continue to gain favor from the capital market. The registered website of the main registered service received D-round financing of 394 million yuan in 2015; Dr. Chun Yu, the largest Internet medical platform in China, received financing of USD 50 million in 2015, and completed the Pre-IPO financing of RMB 1.2 billion in 2016; There are also a number of enterprises such as the clove garden and the medical platform 160, which have also successfully financed in the last two or three years. The Internet medical financing boom has not diminished.
However, the development of mobile medical care is also controversial. There is no face-to-face consultation between doctors and patients. The quality and safety of remote diagnosis can also be ensured. By 2015, national health planning committee made it clear that in addition to the telemedicine medical institutions, and other work involved in medical diagnosis are not allowed to carry out on the Internet.
Cosmetics are compound mixtures made of various raw materials through reasonable deployment and processing. Cosmetics have a wide variety of raw materials with different properties. According to the raw material properties and uses of cosmetics, it can be roughly divided into two categories: matrix raw materials and auxiliary raw materials.
The former is a kind of main raw material of cosmetics, which occupies a large proportion in cosmetic formulations and plays a major functional role in cosmetics. The latter is responsible for shaping, stabilizing or imparting color, fragrance and other properties to cosmetics, which are not used in cosmetic formulations, but are extremely important. Cosmetics are chemical mixtures made of natural, synthetic or extracted substances with different functions as raw materials and processed through production procedures such as heating, stirring and emulsification.
Our company provides various cosmetic raw materials
Beta Arbutin Powder,Cosmetic Raw Materials,Kojic Acid Dipalmitate Powder,Nicotinamide Mononucleotide Powder
XI AN RHINE BIOLOGICAL TECHNOLOGY CO.,LTD , https://www.xianrhinebiotech.com